Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Otitis Externa

  • Author: Ariel A Waitzman, MD, FRCSC; Chief Editor: Ravindhra G Elluru, MD, PhD  more...
 
Updated: Jul 11, 2016
 

Practice Essentials

Otitis externa (OE) is an inflammation or infection of the external auditory canal (EAC), the auricle, or both.[1, 2, 3] This condition can be found in all age groups.[4] See the image below.

Acute otitis externa. Ear canal is red and edemato Acute otitis externa. Ear canal is red and edematous, and discharge is present.

Classification

OE may be classified as follows:

  • Acute diffuse OE - Most common form of OE, typically seen in swimmers
  • Acute localized OE (furunculosis) - Associated with infection of a hair follicle
  • Chronic OE - Same as acute diffuse OE but is of longer duration (>6 weeks)
  • Eczematous (eczematoid) OE - Encompasses various dermatologic conditions (eg, atopic dermatitis, psoriasis, systemic lupus erythematosus, and eczema) that may infect the EAC and cause OE
  • Necrotizing (malignant) OE - Infection that extends into the deeper tissues adjacent to the EAC; occurs primarily in immunocompromised adults (eg, diabetics, patients with AIDS)
  • Otomycosis - Infection of the ear canal from a fungal species (eg, Candida, Aspergillus)

Signs and symptoms

The key physical finding of OE is pain upon palpation of the tragus (anterior to ear canal) or application of traction to the pinna (the hallmark of OE). Patients may also have the following signs and symptoms:

  • Otalgia - Ranges from mild to severe, typically progressing over 1-2 days
  • Hearing loss
  • Ear fullness or pressure
  • Erythema, edema, and narrowing of the EAC
  • Tinnitus
  • Fever (occasionally)
  • Itching (especially in fungal OE or chronic OE)
  • Severe deep pain - Immunocompromised patients may have necrotizing (malignant) OE
  • Discharge - Initially, clear; quickly becomes purulent and foul-smelling
  • Cellulitis of the face or neck or lymphadenopathy of the ipsilateral neck (occasionally)
  • Bilateral symptoms (rare)
  • History of exposure to or activities in water (frequently) (eg, swimming, surfing, kayaking)
  • History of preceding ear trauma (usually) (eg, forceful ear cleaning, use of cotton swabs, or water in the ear canal)

See Clinical Presentation for more detail.

Diagnosis

The patient’s history and physical examination, including otoscopy, usually provide sufficient information for the clinician to make the diagnosis of OE. Note that a patient who is diabetic or immunocompromised with severe pain in the ear should have necrotizing OE excluded by an otolaryngologist.

Laboratory testing

Typically, laboratory studies are not needed, but they may be helpful if the patient is immunocompromised, if the usual treatment measures are ineffective, or if a fungal cause is suspected. Tests may include the following:

  • Gram stain and culture of any discharge from the auditory canal
  • Blood glucose level
  • Urine dipstick

Imaging studies

Imaging studies are not required for most cases of OE. However, radiologic investigation may be helpful if an invasive infection such as necrotizing (malignant) OE is suspected or if the diagnosis of mastoiditis is being considered.

Imaging modalities may include the following:

  • High-resolution computed tomography (CT) - Preferred; better depicts bony erosion [5]
  • Radionucleotide bone scanning
  • Gallium scanning
  • Magnetic resonance imaging (MRI) - Not used as often as the other modalities; may be considered secondarily or if soft-tissue extension is the predominant concern [6]

See Workup for more detail.

Management

Most persons with OE are treated empirically. Primary treatment involves the following:

  • Pain management
  • Removal of debris from the EAC
  • Administration of topical medications to control edema and infection
  • Avoidance of contributing factors

Pharmacotherapy

  • Topical medications (eg, acetic acid in aluminum acetate, hydrocortisone and acetic acid otic solution, alcohol vinegar otic mix)
  • Analgesic agents (eg, acetaminophen, acetaminophen and codeine)
  • Antibiotics (eg, hydrocortisone/neomycin/polymyxin B, otic ofloxacin, otic ciprofloxacin, otic finafloxacin, gentamicin 0.3%/prednisolone 1% ophthalmic, dexamethasone/tobramycin, otic ciprofloxacin and dexamethasone, otic ciprofloxacin and hydrocortisone suspension)
  • Oral antibiotics (eg, ciprofloxacin)
  • Antifungal agents (eg, otic clotrimazole 1% solution, nystatin powder)

Surgery

  • Surgical debridement of the ear canal - Usually reserved for necrotizing OE or for complications of OE (eg, external canal stenosis); often necessary in more severe cases of OE or in cases where a significant amount of discharge is present in the ear; mainstay of treatment for fungal infections
  • Incision and drainage of an abscess

See Treatment and Medication for more detail.

Next

Background

Otitis externa (OE) is an inflammation or infection of the external auditory canal (EAC), the auricle, or both.[1, 2, 3] It is a common disease that can be found in all age groups.[4] OE usually represents an acute bacterial infection of the skin of the ear canal (most commonly attributable to Pseudomonas aeruginosa or Staphylococcus aureus[7] ) but can also be caused by other bacteria, viruses, or a fungal infection (see Pathophysiology and Etiology).

Several factors can contribute to EAC infection and the development of OE, including the following[8] :

  • Absence of cerumen
  • High humidity
  • Retained water in ear canal
  • Increased temperature
  • Local trauma (eg, use of cotton swabs or hearing aids)

Aquatic athletes are particularly prone to the development of OE because repeated exposure to water results in removal of cerumen and drying of the EAC. Retained water in the ear canal can cause maceration of the skin and a milieu conducive to bacterial or fungal proliferation. OE occurs more often in the summer months, when swimming is more common,[4, 8] and it is also common in tropical areas.[9] Individuals with allergic conditions (eg, eczema, allergic rhinitis, and asthma) are also at significantly higher risk for OE.[10, 11]

Although OE rarely causes prolonged problems or serious complications, the infection is responsible for significant pain and acute morbidity (see Presentation). Prompt diagnosis (see DDx and Workup) and appropriate therapy (see Treatment) cure the majority of cases without complications; however, patients who are diabetic, immunocompromised, or untreated may develop necrotizing (malignant) OE, a potentially life-threatening infection.

Classification

OE may be classified as follows:

  • Acute diffuse OE – This is the most common form of OE, typically seen in swimmers; it is characterized by rapid onset (generally within 48 hours) and symptoms of EAC inflammation (eg, otalgia, itching, or fullness, with or without hearing loss or jaw pain) as well as tenderness of the tragus or pinna or diffuse ear edema or erythema or both, with or without otorrhea, regional lymphadenitis, tympanic membrane erythema, or cellulitis of the pinna [9]
  • Acute localized OE – This condition, also known as furunculosis, is associated with infection of a hair follicle
  • Chronic OE – This is the same as acute diffuse OE but is of longer duration (>6 weeks)
  • Eczematous (eczematoid) OE – This encompasses various dermatologic conditions (eg, atopic dermatitis, psoriasis, systemic lupus erythematosus, and eczema) that may infect the EAC and cause OE
  • Necrotizing (malignant) OE – This is an infection that extends into the deeper tissues adjacent to the EAC; it primarily occurs in adult patients who are immunocompromised (eg, as a result of diabetes mellitus or AIDS) and is rarely described in children; it may result in cases of cellulitis and osteomyelitis (see Cellulitis, Osteomyelitis, and Chronic Osteomyelitis Imaging)
  • Otomycosis - Infection of the ear canal secondary to fungus species such as Candida or Aspergillus

In 2014, the American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) released updated clinical practice guidelines for the diagnosis and treatment of acute OE (see Guidelines).[12]

Previous
Next

Anatomy

The external ear (see the image below) consists of the auricle and the EAC.

Acute otitis externa. Ear canal is red and edemato Acute otitis externa. Ear canal is red and edematous, and discharge is present.

The auricle is composed of elastic cartilage with the overlying skin attached directly to the perichondrium. It begins to form during week 6 of gestation through consolidation of portions of the mesoderm of the first and second branchial arches, giving rise to the His hillocks. The first three hillocks are derived from the first arch, the second three from the second arch. The auricle reaches adult shape by the week 20 of gestation, but the adult size is not reached until the age of 9 years.

The EAC begins to form during week 8 of gestation, when the surface ectoderm of the first pharyngeal groove thickens and grows toward the middle ear. This core of tissue begins to resorb by week 21 of gestation to form a channel that is complete by week 28. The canal reaches adult size by the age of 9 years and ossifies completely by the age of 3 years. The EAC is related to the mandibular fossa anteriorly, the mastoid air cells posteriorly, the middle cranial fossa superiorly, and the parotid gland inferiorly.

The EAC is lined with squamous epithelium and is approximately 2.5 cm long in adults. Its function is to transmit sound to the middle ear while protecting more proximal structures from foreign bodies and any changes in environmental conditions. The outer one third of the canal is primarily cartilaginous and is oriented superiorly and posteriorly; the inner two thirds of the canal is osseous, is covered with thinner skin that adheres tightly, and is oriented inferiorly and anteriorly; this portion of the canal is devoid of any apocrine glands or hair follicles.

The thicker skin over the outer (cartilaginous) portion of the EAC contains apopilosebaceous units comprising apocrine and eccrine glands that secrete their products around the base of a hair follicle. These secretions combine with sloughed squamous epithelium (cerumen) to coat the EAC and maintain an acidic pH (4-5). This cerumen coat migrates from the isthmus of the EAC to the lateral part, and its waxy nature protects the underlying epithelium from maceration or skin breakdown. The quantity of cerumen produced varies widely among individuals.

The acidity of the cerumen inhibits bacterial or fungal growth. Whereas a paucity of cerumen allows bacterial growth, an excess can create an environment ideal for bacterial invasion by allowing retention of water and debris (as when the EAC is regularly exposed to water). Localized trauma from foreign objects placed in the ear can also lead to direct bacterial invasion in the ear canal. Once an infection becomes established, localized maceration and inflammation occur, which lead to symptoms.

Previous
Next

Pathophysiology

OE is a superficial infection of the skin in the EAC. The processes involved in the development of OE can be divided into the following four categories:

  • Obstruction (eg, cerumen buildup, surfer’s exostosis, or a narrow or tortuous canal), resulting in water retention
  • Absence of cerumen, which may occur as a result of repeated water exposure or overcleaning the ear canal
  • Trauma
  • Alteration of the pH of the ear canal

If moisture is trapped in the EAC, it may cause maceration of the skin and provide a good breeding ground for bacteria. This may occur after swimming (especially in contaminated water) or bathing—hence the common lay term “swimmer’s ear.” It may also occur in hot humid weather. Obstruction of the EAC by excessive cerumen, debris, surfer’s exostosis, or a narrow and tortuous canal may also lead to infection by means of moisture retention.

Trauma to the EAC allows invasion of bacteria into the damaged skin. This often occurs after attempts at cleaning the ear with a cotton swab, paper clip, or any other utensil that can fit into the ear.

Once infection is established, an inflammatory response occurs with skin edema. Exudate and pus often appear in the EAC as well. If severe, the infection may spread and cause a cellulitis of the face or neck.

Necrotizing (malignant) OE is a rare complication that occurs in patients who are immunocompromised or in those who have received radiotherapy to the skull base. In this condition, bacteria invade the deeper underlying structures of the soft tissues and cause osteomyelitis of the temporal bone. This is a life-threatening disorder with an overall mortality that historically has approached 50%.

Previous
Next

Etiology

OE is most often caused by a bacterial pathogen; other varieties include fungal OE (otomycosis) and eczematoid (psoriatic) OE.[13] In one study, 91% of cases of OE were caused by bacteria.[7] Others have found that as many as 40% of cases of OE have no primary identifiable microorganism as a causative agent. The most common causative bacteria are Pseudomonas species (38% of all cases),[13] Staphylococcus species, and anaerobes and gram-negative organisms.

Fungal OE may result from overtreatment with topical antibiotics or may arise de novo from moisture trapped in the EAC. It is caused by Aspergillus 80-90% of the time; Candida and other organisms have also been isolated. This condition is characterized by long, white, filamentous hyphae growing from the skin surface. Besides otorrhea, erythema and edema of the EAC are common. In severe cases, soft tissue stenosis may be present. Extension of the infection may manifest as cellulitic skin changes involving the concha of the auricle and the tragus.

Eczematoid (psoriatic) OE is associated with the following conditions:

  • Eczema
  • Seborrhea
  • Neurodermatitis
  • Contact dermatitis from earrings or hearing aid use
  • Purulent otitis media with perforation of the tympanic membrane and drainage; this may mimic OE to an extent, but it is usually painless and does not cause any swelling of the ear canal
  • Sensitivity to topical medications

Chronic OE is a fairly common condition that is sometimes the result of incomplete treatment of acute OE.[14] More often, however, chronic OE is caused by overmanipulation of the ear canal as a consequence of cleaning and scratching. Such overmanipulation results in a low-grade inflammatory response that causes further itching of the skin. Eventually, the skin thickens, and canal stenosis may occur.

Necrotizing OE occurs in patients who are immunocompromised and represents a true osteomyelitis of the temporal bone.

Risk factors for OE include the following:

  • Previous episodes of OE
  • Swimming, diving, or participating in aquatic activities
  • Use of earplugs or probing of the EAC (possibly secondary to trauma to the EAC)
  • Hot, humid weather
  • Use of a hearing aid
  • Coexistence of eczema, allergic rhinitis, or asthma
  • Comorbidities such as diabetes mellitus, AIDS, leukopenia, or malnutrition
Previous
Next

Epidemiology

United States and international statistics

OE is found in all regions of the United States, occurring in 4 of every 1000 people annually.[8, 10] The infection is believed to be more prevalent in hot and humid conditions such as prevail during the summer months, presumably because participation in aquatic activities is higher.[4, 8, 15] Acute, chronic, and eczematous OE are also common. Necrotizing OE is rare.

The international frequencies of OE have not been fully determined; however, the incidence is increased in tropical countries.[9]

Age-, sex-, and race-related demographics

Although the infection can affect all age groups, OE appears to be most prevalent in the older pediatric and young adult population, with a peak incidence in children aged 7-12 years.[13] A single epidemiologic study from the United Kingdom found a similar 12-month prevalence for individuals aged 5-64 years and a slight increase in prevalence for those older than 65 years.[4] This was postulated to occur secondary to an increase in comorbidities, as well as an increase in the use of hearing aids, which may cause trauma to the EAC.

OE affects both sexes equally. No racial predilection has been established, though people in some racial groups have small ear canals, which may predispose them to obstruction and infection.

Previous
Next

Prognosis

Most incidents of OE resolve without difficulty. The majority of patients improve within 48-72 hours of antibiotic administration. Failure to improve within 2-3 days should call the diagnosis into question and prompt the physician to reevaluate the patient. OE usually resolves fully in 7-10 days. Resolution of eczematoid OE occurs with control of the primary skin condition. In some patients with OE, the ear must be debrided for full resolution. Surgical incision and drainage are sometimes necessary.

In some patients, OE can cause severe otalgia necessitating administration of narcotic pain relievers. Pain usually improves 2-5 days after initiating therapy. Temporary hearing loss is common secondary to canal occlusion. Severe infections may cause lymphadenitis or cellulitis of the face or neck.

If left untreated, the infection may invade the deeper adjacent structures and progress to necrotizing (malignant) OE, a serious condition that requires prolonged treatment and often results in severe morbidity or mortality. This complication is almost exclusively seen in immunocompromised patients, such as those with diabetes, AIDS patients, those undergoing chemotherapy, and patients taking immunosuppressant medications (eg, glucocorticoids). Pseudomonas is the inciting organism in the vast majority of cases.

When necrotizing OE develops, mortality is in the 20% range among adults, mostly because of the associated comorbidities and the rapid extension of the infection to include sepsis or intracranial extension. If left untreated, necrotizing OE has a mortality approaching 50%. This complication should be suspected if the patient’s pain and tenderness seem out of proportion to clinical appearance or if granulation tissue is seen in the ear canal.

Previous
Next

Patient Education

OE is a common problem, with risk factors that are easily avoided. Education regarding ways of keeping the ear dry is helpful. Preventive use of acidifying drops is encouraged in patients with recurrent OE. Avoidance of the use of cotton-tipped swabs to remove ear cerumen should be discussed with patients. Improper use of cotton-tipped applicator sticks simply packs cerumen into the canal and can cause trauma to the tympanic membrane.

Patients should be made aware that when OE does strike, it can usually be resolved in a short time, with few if any complications.

For patient education resources, see the Ear, Nose, and Throat Center, as well as Swimmer’s Ear.

Previous
 
 
Contributor Information and Disclosures
Author

Ariel A Waitzman, MD, FRCSC Assistant Professor of Otolaryngology, Wayne State University School of Medicine

Ariel A Waitzman, MD, FRCSC is a member of the following medical societies: Canadian Society of Otolaryngology-Head & Neck Surgery, American Academy of Otolaryngology-Head and Neck Surgery, American Medical Association, Michigan State Medical Society

Disclosure: Nothing to disclose.

Chief Editor

Ravindhra G Elluru, MD, PhD Professor, Wright State University, Boonshoft School of Medicine; Pediatric Otolaryngologist, Department of Otolaryngology, Dayton Children's Hospital Medical Center

Ravindhra G Elluru, MD, PhD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American Bronchoesophagological Association, American College of Surgeons, American Medical Association, Association for Research in Otolaryngology, Society for Ear, Nose and Throat Advances in Children, Triological Society, American Society for Cell Biology

Disclosure: Nothing to disclose.

Acknowledgements

Jerry Balentine, DO Professor of Emergency Medicine, New York College of Osteopathic Medicine; Executive Vice President, Chief Medical Officer, Attending Physician in Department of Emergency Medicine, St. Barnabas Hospital

Jerry Balentine, DO is a member of the following medical societies: American College of Emergency Physicians, American College of Osteopathic Emergency Physicians, American College of Physician Executives, American Osteopathic Association, and New York Academy of Medicine

Disclosure: Nothing to disclose.

anjiv K Bhalla, MD Consulting Staff, Department of Emergency Medicine, St Paul's Hospital of Vancouver, St Joseph's Hospital of Hamilton

Sanjiv K Bhalla, MD is a member of the following medical societies: American College of Emergency Physicians, British Columbia Medical Association, Canadian Association of Emergency Physicians, Canadian Medical Association, Canadian Medical Protective Association, and Ontario Medical Association

Disclosure: Nothing to disclose.

Orval Brown, MD Director of Otolaryngology Clinic, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center at Dallas

Orval Brown, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American Bronchoesophagological Association, American College of Surgeons, American Medical Association, American Society of Pediatric Otolaryngology, Society for Ear, Nose and Throat Advances in Children, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Nothing to disclose.

Pamela L Dyne, MD Professor of Clinical Medicine/Emergency Medicine, David Geffen School of Medicine at UCLA; Attending Physician, Department of Emergency Medicine, Olive View-UCLA Medical Center

Pamela L Dyne, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Mark W Fourre, MD Program Director, Department of Emergency Medicine, Maine Medical Center; Associate Clinical Professor, Department of Surgery, University of Vermont School of Medicine

Disclosure: Nothing to disclose.

Joseph P Garry, MD, FACSM, FAAFP Associate Professor, Department of Family and Community Medicine, University of Minnesota Medical School

Joseph P Garry, MD, FACSM, FAAFP is a member of the following medical societies: American Academy of Family Physicians, American College of Sports Medicine, American Medical Society for Sports Medicine, and Minnesota Medical Association

Disclosure: Nothing to disclose.

Gerard J Gianoli, MD Clinical Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Tulane University School of Medicine; Vice President, The Ear and Balance Institute; Chief Executive Officer, Ponchartrain Surgery Center

Gerard J Gianoli, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Neurotology Society, American Otological Society, Society of University Otolaryngologists-Head and Neck Surgeons, and Triological Society

Disclosure: Vesticon, Inc. None Board membership

Ashutosh Kacker, MD Associate Professor of Otorhinolaryngology, Department of Otolaryngology, Weill Cornell Medical College; Associate Attending Physician, Otolaryngologist, New York Presbyterian Hospital; Attending Physician, New York Hospital of Queens; Attending Physician, Lenox Hill Hospital

Ashutosh Kacker, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Rhinologic Society, and Triological Society

Disclosure: Nothing to disclose.

Samuel Lee, MD, MS Resident Physician, Department of Emergency Medicine, Wayne State University School of Medicine, Detroit Receiving Hospital

Disclosure: Nothing to disclose.

John E McClay, MD Associate Professor of Pediatric Otolaryngology, Department of Otolaryngology-Head and Neck Surgery, Children's Hospital of Dallas, University of Texas Southwestern Medical School

John E McClay, MD is a member of the following medical societies: American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, and American Medical Association

Disclosure: Nothing to disclose.

Adam J Rosh, MD Assistant Professor, Department of Emergency Medicine, Wayne State University/Detroit Receiving Hospital

Adam J Rosh, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, and Society for Academic Emergency Medicine

Disclosure: Nothing to disclose.

Andrew L Sherman, MD, MS Associate Professor of Clinical Rehabilitation Medicine, Vice Chairman, Chief of Spine and Musculoskeletal Services, Program Director, SCI Fellowship and PMR Residency Programs, Department of Rehabilitation Medicine, University of Miami, Leonard A Miller School of Medicine

Andrew L Sherman, MD, MS is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation, American Association of Neuromuscular and Electrodiagnostic Medicine, American Medical Association, and Association of Academic Physiatrists

Disclosure: Pfizer Honoraria Speaking and teaching

Jack A Shohet, MD President, Shohet Ear Associates Medical Group, Inc; Associate Clinical Professor, Department of Otolaryngology-Head and Neck Surgery, University of California, Irvine, School of Medicine

Jack A Shohet, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Medical Association, American Neurotology Society, American Tinnitus Association, and California Medical Association

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Russell D White, MD Professor of Medicine, Professor of Orthopedic Surgery, Director of Sports Medicine Fellowship Program, Medical Director, Sports Medicine Center, Head Team Physician, University of Missouri-Kansas City Intercollegiate Athletic Program, Department of Community and Family Medicine, University of Missouri-Kansas City School of Medicine, Truman Medical Center-Lakewood

Russell D White, MD, is a member of the following medical societies: Alpha Omega Alpha, American Academy of Family Physicians, American Association of Clinical Endocrinologists, American College of Sports Medicine, American Diabetes Association, and American Medical Society for Sports Medicine

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Craig C Young, MD Professor, Departments of Orthopedic Surgery and Community and Family Medicine, Medical Director of Sports Medicine, Director of Primary Care Sports Medicine Fellowship, Medical College of Wisconsin

Craig C Young, MD is a member of the following medical societies: American Academy of Family Physicians, American College of Sports Medicine, American Medical Society for Sports Medicine, and Phi Beta Kappa

Disclosure: Nothing to disclose.

References
  1. Bojrab DI, Bruderly T, Abdulrazzak Y. Otitis externa. Otolaryngol Clin North Am. 1996 Oct. 29(5):761-82. [Medline].

  2. Cantor RM. Otitis externa and otitis media. A new look at old problems. Emerg Med Clin North Am. 1995 May. 13(2):445-55. [Medline].

  3. Rosenfeld RM, Brown L, Cannon CR, Dolor RJ, Ganiats TG, Hannley M, et al. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2006 Apr. 134(4 Suppl):S4-23. [Medline].

  4. Rowlands S, Devalia H, Smith C, Hubbard R, Dean A. Otitis externa in UK general practice: a survey using the UK General Practice Research Database. Br J Gen Pract. 2001 Jul. 51(468):533-8. [Medline]. [Full Text].

  5. Grandis JR, Curtin HD, Yu VL. Necrotizing (malignant) external otitis: prospective comparison of CT and MR imaging in diagnosis and follow-up. Radiology. 1995 Aug. 196(2):499-504. [Medline]. [Full Text].

  6. Hegde AN, Mohan S, Pandya A, Shah GV. Imaging in infections of the head and neck. Neuroimaging Clin N Am. 2012 Nov. 22(4):727-54. [Medline].

  7. Clark WB, Brook I, Bianki D, Thompson DH. Microbiology of otitis externa. Otolaryngol Head Neck Surg. 1997 Jan. 116(1):23-5. [Medline].

  8. Holten KB, Gick J. Management of the patient with otitis externa. J Fam Pract. 2001 Apr. 50(4):353-60. [Medline].

  9. Hughes E, Lee JH. Otitis externa. Pediatr Rev. 2001 Jun. 22(6):191-7. [Medline].

  10. Osguthorpe JD, Nielsen DR. Otitis externa: Review and clinical update. Am Fam Physician. 2006 Nov 1. 74(9):1510-6. [Medline].

  11. Russell JD, Donnelly M, McShane DP, Alun-Jones T, Walsh M. What causes acute otitis externa?. J Laryngol Otol. 1993 Oct. 107(10):898-901. [Medline].

  12. Rosenfeld RM, Schwartz SR, Cannon CR, Roland PS, Simon GR, Kumar KA, et al. Clinical practice guideline: acute otitis externa executive summary. Otolaryngol Head Neck Surg. 2014 Feb. 150(2):161-8. [Medline].

  13. Roland PS, Stroman DW. Microbiology of acute otitis externa. Laryngoscope. 2002 Jul. 112(7 Pt 1):1166-77. [Medline].

  14. Roland PS. Chronic external otitis. Ear Nose Throat J. 2001 Jun. 80(6 Suppl):12-6. [Medline].

  15. Centers for Disease Control and Prevention. Estimated burden of acute otitis externa--United States, 2003-2007. MMWR Morb Mortal Wkly Rep. 2011 May 20. 60(19):605-9. [Medline].

  16. Alva B, Prasad KC, Prasad SC, Pallavi S. Temporal bone osteomyelitis and temporoparietal abscess secondary to malignant otitis externa. J Laryngol Otol. 2009 Nov. 123(11):1288-91. [Medline].

  17. Kim D, Bhimani M. Ramsay Hunt syndrome presenting as simple otitis externa. CJEM. 2008 May. 10(3):247-50. [Medline].

  18. Zhang T, Dai C, Wang Z. The misdiagnosis of external auditory canal carcinoma. Eur Arch Otorhinolaryngol. 2012 Aug 25. [Medline].

  19. Kaushik V, Malik T, Saeed SR. Interventions for acute otitis externa. Cochrane Database Syst Rev. 2010 Jan 20. CD004740. [Medline].

  20. Wall GM, Stroman DW, Roland PS, Dohar J. Ciprofloxacin 0.3%/dexamethasone 0.1% sterile otic suspension for the topical treatment of ear infections: a review of the literature. Pediatr Infect Dis J. 2009 Feb. 28(2):141-4. [Medline].

  21. Rosenfeld RM, Singer M, Wasserman JM, Stinnett SS. Systematic review of topical antimicrobial therapy for acute otitis externa. Otolaryngol Head Neck Surg. 2006 Apr. 134(4 Suppl):S24-48. [Medline].

  22. Collier SA, Hlavsa MC, Piercefield EW, Beach MJ. Antimicrobial and Analgesic Prescribing Patterns for Acute Otitis Externa, 2004-2010. Otolaryngol Head Neck Surg. 2012 Nov 6. [Medline].

  23. Roland PS, Belcher BP, Bettis R, Makabale RL, et al. A single topical agent is clinically equivalent to the combination of topical and oral antibiotic treatment for otitis externa. Am J Otolaryngol. 2008 Jul-Aug. 29(4):255-61. [Medline].

  24. Mosges R, Nematian-Samani M, Hellmich M, Shah-Hosseini K. A meta-analysis of the efficacy of quinolone containing otics in comparison to antibiotic-steroid combination drugs in the local treatment of otitis externa. Curr Med Res Opin. 2011 Oct. 27(10):2053-60. [Medline].

  25. Brooks M. FDA clears finafloxacin ear drops (Xtoro) for swimmer's ear. Medscape Medical News. December 17, 2014. [Full Text].

  26. FDA approves Xtoro to treat swimmer’s ear. U.S. Food and Drug Administration. Available at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427274.htm. Accessed: December 20, 2014.

  27. Caffier PP, Harth W, Mayelzadeh B, Haupt H, Sedlmaier B. Tacrolimus: a new option in therapy-resistant chronic external otitis. Laryngoscope. 2007 Jun. 117(6):1046-52. [Medline].

 
Previous
Next
 
Acute otitis externa. Ear canal is red and edematous, and discharge is present.
Otitis externa with ear wick in place. Note discharge from canal and swelling of canal.
Anatomy of external and middle ear.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.